covid 19 medicine

Glenmark Pharma stocks rise nearly 9% on DCGI nod for clinical trials of COVID-19 tablets

Glenmark Pharma stocks rise nearly 9% on DCGI nod for clinical trials of COVID-19 tablets

Shares of Glenmark Pharmaceuticals on Thursday gained nearly 9 per cent after the company said it has received approval from DCGI to cond...Read More

Free Press Journal

www.freepressjournal.in